Design point results show that a 316 MWt reactor produces a thrust and specific impulse of 66.6 kN and 917 s, respectively. The same reactor can be run at 73.8 kWt to produce the necessary 16.7 kW electric power with a Brayton cycle generator. This demonstrates the feasibility of BNTR operation with a NERVAderived reactor but also indicates that the reactor control system must be able to operate with precision across a wide power range, and that the transient analysis of reactor decay heat merits future investigation.Results also identify a significant reactor pressure-drop limitation during propulsion and power-generation operation that is caused by poor tie tube thermal conductivity. This leads to the conclusion that, while BNTR operation is possible with a NERVA-derived reactor, doing so requires careful consideration of the Brayton cycle design point and fuel element survivability.
The development of new reusable space launch vehicle concepts has lead to the need for more advanced engine cycles. Many two-stage vehicle concepts rely on advanced gas turbine engines that can propel the first stage of the launch vehicle from a runway up to Mach 5 or faster. One prospective engine for these vehicles is the Air Turborocket (ATR). The ATR is an innovative aircraft engine flowpath that is intended to extend the operating range of a conventional gas turbine engine. This is done by moving the turbine out of the core engine flow, alleviating the traditional limit on the turbine inlet temperature. This paper presents the analysis of an ATR engine for a reusable space launch vehicle and some of the practical problems that will be encountered in the development of this engine.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.